ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 384 filers reported holding ENCOMPASS HEALTH CORP in Q2 2023. The put-call ratio across all filers is 2.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,242,284 | -29.5% | 48,277 | -29.0% | 0.00% | 0.0% |
| Q2 2023 | $4,601,774 | +208.3% | 67,963 | +146.3% | 0.00% | +100.0% |
| Q1 2023 | $1,492,674 | -9.1% | 27,591 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,641,485 | +417.8% | 27,445 | +292.2% | 0.00% | – |
| Q3 2022 | $317,000 | -3.1% | 6,998 | +19.7% | 0.00% | – |
| Q2 2022 | $327,000 | -12.8% | 5,845 | +10.9% | 0.00% | – |
| Q1 2022 | $375,000 | +20.6% | 5,271 | +10.5% | 0.00% | – |
| Q4 2021 | $311,000 | -11.1% | 4,772 | +2.4% | 0.00% | – |
| Q3 2021 | $350,000 | +68.3% | 4,661 | +74.6% | 0.00% | – |
| Q2 2021 | $208,000 | -1.0% | 2,669 | +5.2% | 0.00% | – |
| Q4 2020 | $210,000 | -81.7% | 2,537 | -86.0% | 0.00% | -100.0% |
| Q2 2019 | $1,145,000 | +48.1% | 18,077 | +36.6% | 0.00% | – |
| Q1 2019 | $773,000 | +69.5% | 13,230 | +79.1% | 0.00% | – |
| Q4 2018 | $456,000 | +60.6% | 7,385 | +102.9% | 0.00% | – |
| Q3 2018 | $284,000 | – | 3,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 400,000 | $25,612,000 | 9.91% |
| REINHART PARTNERS, LLC. | 687,133 | $43,997,000 | 4.26% |
| RK Capital | 147,290 | $9,431,000 | 4.24% |
| HealthCor Management, L.P. | 1,525,809 | $97,698,000 | 4.18% |
| Integral Health Asset Management, LLC | 115,000 | $7,363,000 | 3.24% |
| Sivik Global Healthcare LLC | 32,500 | $7,733,000 | 3.05% |
| Copeland Capital Management, LLC | 635,514 | $40,692,000 | 2.48% |
| Rock Springs Capital Management LP | 815,000 | $52,184,000 | 2.16% |
| Endurant Capital Management LP | 55,614 | $3,561,000 | 1.61% |
| Advantage Alpha Capital Partners LP | 70,005 | $4,482,000 | 1.60% |